Seminars in Hematology
Volume 44, Supplement 1 , Pages 25-31, January 2007

New Targeted Therapies for Chronic Myelogenous Leukemia: Opportunities to Overcome Imatinib Resistance

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(06)00256-3

doi:10.1053/j.seminhematol.2006.12.003

Seminars in Hematology
Volume 44, Supplement 1 , Pages 25-31, January 2007

Article Tools